Xenon Pharmaceuticals
XENE
#2957
Rank
NZ$9.62 B
Marketcap
NZ$100.82
Share price
2.17%
Change (1 day)
72.29%
Change (1 year)

Market capitalization of Xenon Pharmaceuticals (XENE)

Market cap: NZ$9.62 Billion

As of April 2026 Xenon Pharmaceuticals has a market cap of NZ$9.62 Billion. This makes Xenon Pharmaceuticals the world's 2957th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Xenon Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$9.62 B60.8%
2025NZ$5.98 B13.98%
2024NZ$5.24 B-4.26%
2023NZ$5.48 B41.15%
2022NZ$3.88 B64.62%
2021NZ$2.35 B216.16%
2020NZ$0.74 B36.25%
2019NZ$0.54 B126.12%
2018NZ$0.24 B238.36%
2017NZ$71.59 M-64.01%
2016NZ$0.19 B17.7%
2015NZ$0.16 B-52.73%
2014NZ$0.35 B

End of Day market cap according to different sources

On Apr 17th, 2026 the market cap of Xenon Pharmaceuticals was reported to be:

NZ$8.38 Billion
by Nasdaq info icon info icon
NZ$9.62 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Coherus BioSciences
CHRS
NZ$0.50 B-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Atara Biotherapeutics
ATRA
NZ$72.78 M-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA